Literature DB >> 8535643

The history of the use of sulphasalazine in rheumatology.

R S Amos1.   

Abstract

Sulphasalazine was initially used more than 50 yr ago to treat inflammatory arthritis but fell into disuse, only to be revived 25 yr ago for rheumatoid arthritis. Since then its place as a second-line agent has been established and its toxicity profile has been outlined. Subsequently, its use has been widened to include other inflammatory rheumatic diseases, with strong suggestions that it may be useful for several indications. The history of its initial use, its reintroduction and the establishment of its place in modern rheumatology are reviewed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8535643

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  2 in total

Review 1.  Influence of treatments on cell adhesion molecules in patients with systemic lupus erythematosus and rheumatoid arthritis: a review.

Authors:  Lorena Flor da Rosa Franchi Santos; Neide Tomimura Costa; Michael Maes; Andréa Name Colado Simão; Isaias Dichi
Journal:  Inflammopharmacology       Date:  2019-12-09       Impact factor: 4.473

2.  Is it Crohn's disease? A severe systemic granulomatous reaction to sulfasalazine in patient with rheumatoid arthritis.

Authors:  L G Quallich; J Greenson; H M Haftel; R J Fontana
Journal:  BMC Gastroenterol       Date:  2001-08-29       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.